Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of An Oral Treatment with the PPAR-γ-Acting Cannabinoid VCE-003.2 Against the Inflammation-Driven Neuronal Deterioration in Experimental Parkinson’s Disease
Sonia Burgaz, Concepción García, María Gómez‐Cañas, et al.
Molecules (2019) Vol. 24, Iss. 15, pp. 2702-2702
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain
Barbara Stella, Francesca Baratta, Carlo Della Pepa, et al.
Drugs (2021) Vol. 81, Iss. 13, pp. 1513-1557
Open Access | Times Cited: 104
A systematic review of minor phytocannabinoids with promising neuroprotective potential
Nicole L. Stone, Alexandra J. Murphy, Timothy J. England, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 19, pp. 4330-4352
Open Access | Times Cited: 86
Toll-like receptor signalling as a cannabinoid target
Melody Cui Sun, Almudena Otálora-Alcaraz, Jack Prenderville, et al.
Biochemical Pharmacology (2024) Vol. 222, pp. 116082-116082
Open Access | Times Cited: 11
Major Phytocannabinoids and Their Related Compounds: Should We Only Search for Drugs That Act on Cannabinoid Receptors?
Leontina Elena Filipiuc, Daniela Carmen Ababei, Teodora Alexa‐Stratulat, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1823-1823
Open Access | Times Cited: 56
Microglia and BDNF at the crossroads of stressor related disorders: Towards a unique trophic phenotype
Natalie Prowse, Shawn Hayley
Neuroscience & Biobehavioral Reviews (2021) Vol. 131, pp. 135-163
Open Access | Times Cited: 48
LncRNA miR-17-92a-1 cluster host gene (MIR17HG) promotes neuronal damage and microglial activation by targeting the microRNA-153-3p/alpha-synuclein axis in Parkinson’s disease
Jianzhong Zhang, Yunsheng Yang, Chaoyang Zhou, et al.
Bioengineered (2022) Vol. 13, Iss. 2, pp. 4493-4516
Open Access | Times Cited: 29
Relevance of Peroxisome Proliferator Activated Receptors in Multitarget Paradigm Associated with the Endocannabinoid System
Ana Lago-Fernandez, Sara Zarzo-Arias, Nadine Jagerovic, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1001-1001
Open Access | Times Cited: 39
The Use of Compounds Derived from Cannabis sativa in the Treatment of Epilepsy, Painful Conditions, and Neuropsychiatric and Neurodegenerative Disorders
Anna Stasiłowicz-Krzemień, Wiktoria Nogalska, Zofia Maszewska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5749-5749
Open Access | Times Cited: 6
Possible Role of Cannabis in the Management of Neuroinflammation in Patients with Post-COVID Condition
Noemí Cárdenas‐Rodríguez, Iván Ignacio‐Mejía, José Correa‐Basurto, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3805-3805
Open Access | Times Cited: 5
Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies
Vamsi Reddy, Dayton Grogan, Meenakshi Ahluwalia, et al.
The EPMA Journal (2020) Vol. 11, Iss. 2, pp. 217-250
Open Access | Times Cited: 35
Cannabinoids in traumatic brain injury and related neuropathologies: preclinical and clinical research on endogenous, plant-derived, and synthetic compounds
Brittney R. Lins, Chidozie C. Anyaegbu, Sarah C. Hellewell, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 12
Potential Neuroprotective Effect of the Endocannabinoid System on Parkinson’s Disease
María Fernanda Urmeneta-Ortíz, Aldo Rafael Tejeda-Martínez, Orfil González‐Reynoso, et al.
Parkinson s Disease (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 4
Cannabinoid Quinones—A Review and Novel Observations
Natalya M. Kogan, Maximilian Peters, Raphael Mechoulam
Molecules (2021) Vol. 26, Iss. 6, pp. 1761-1761
Open Access | Times Cited: 27
Neuroprotection with the Cannabidiol Quinone Derivative VCE-004.8 (EHP-101) against 6-Hydroxydopamine in Cell and Murine Models of Parkinson’s Disease
Sonia Burgaz, Concepción García, María Gómez‐Cañas, et al.
Molecules (2021) Vol. 26, Iss. 11, pp. 3245-3245
Open Access | Times Cited: 26
Multilayered neuroprotection by cannabinoids in neurodegenerative diseases
Ahmed Hasbi, Susan R. George
Exploration of Neuroprotective Therapy (2025) Vol. 5
Open Access
Multilayered neuroprotection by cannabinoids in neurodegenerative diseases
Ahmed Hasbi, Susan R. George
Exploration of Neuroprotective Therapy (2025) Vol. 5
Open Access
Neuroprotection with the cannabigerol quinone derivative VCE-003.2 and its analogs CBGA-Q and CBGA-Q-Salt in Parkinson's disease using 6-hydroxydopamine-lesioned mice
Sonia Burgaz, Concepción García, María Gómez‐Cañas, et al.
Molecular and Cellular Neuroscience (2020) Vol. 110, pp. 103583-103583
Closed Access | Times Cited: 24
Use of phytocanabinoids in animal models of parkinson's disease: systematic review
Amanda de Deus Ferreira Alves, Fernanda Carolina Ribeiro Dias, Pabyton Gonçalves Cadena, et al.
NeuroToxicology (2024) Vol. 105, pp. 34-44
Closed Access | Times Cited: 3
Novel CBG Derivatives Can Reduce Inflammation, Pain and Obesity
Natalya M. Kogan, Yarden Lavi, Louise M. Topping, et al.
Molecules (2021) Vol. 26, Iss. 18, pp. 5601-5601
Open Access | Times Cited: 20
Novel Synthesis of C-Methylated Phytocannabinoids Bearing Anti-inflammatory Properties
Yarden Lavi, Natalya M. Kogan, Louise M. Topping, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 8, pp. 5536-5549
Open Access | Times Cited: 7
Unveiling the Potential of Phytocannabinoids: Exploring Marijuana’s Lesser-Known Constituents for Neurological Disorders
Balapal S. Basavarajappa, Shivakumar Subbanna
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1296-1296
Open Access | Times Cited: 2
Cannabis Phytochemicals: A Review of Phytocannabinoid Chemistry and Bioactivity as Neuroprotective Agents
Dylan T. Marsh, Scott D. Smid
Australian Journal of Chemistry (2020) Vol. 74, Iss. 6, pp. 388-404
Closed Access | Times Cited: 16
The effects of PPAR-γ agonist pioglitazone on anxiety and depression-like behaviors in lipopolysaccharide injected rats
Farimah Beheshti, Mahmoud Hosseini, Milad Hashemzehi, et al.
Toxin Reviews (2019) Vol. 40, Iss. 4, pp. 1223-1232
Closed Access | Times Cited: 11
Therapeutic Application of Modulators of Endogenous Cannabinoid System in Parkinson’s Disease
Л. Г. Хаспеков, С. Н. Иллариошкин
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8520-8520
Open Access | Times Cited: 1
Behavioral effects of two cannabidiol and cannabigerol-rich formulas on mice
Marinella Carone, Marika Premoli, Sara Anna Bonini, et al.
Heliyon (2024) Vol. 10, Iss. 21, pp. e39938-e39938
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top